Stockreport

Opiant awarded $7.4M NIH grant to support OPNT003 development; shares ahead 2% premarket [Seeking Alpha]

Opiant Pharmaceuticals, Inc.  (OPNT) 
Last opiant pharmaceuticals, inc. earnings: 3/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opiant.com/investor-overview
PDF Opiant awarded $7.4M NIH grant to support OPNT003 development; shares ahead 2% premarketThinly traded nano cap Opiant Pharmaceuticals (NASDAQ:OPNT) is up2% premarket, al [Read more]